Back

Inotersen improved quality of life, polyneuropathy and cardiomyopathy in a diverse group of patients with hereditary transthyretin amyloidosis in the phase 3 study NEURO-TTR

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardiomyopathies: various aspects Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Steve Hughes

Ionis Pharmaceuticals Inc, Carlsbad (United States of America)

9 More presentations in this session

Presentation thumbnail
Doctor O. Anupraiwan (Nonthaburi, TH)
Abstract
Presentation thumbnail
Associate Professor A. Frustaci (Rome, IT)
Presentation thumbnail
Doctor F. Escher (Berlin, DE)
Abstract
Presentation thumbnail
Professor T. Damy (Creteil, FR)
Abstract
Presentation thumbnail
Associate Professor S. Peters (Elze, DE)

Access the full session

Session thumbnail
Poster Session 1 - Cardiomyopathies: various aspects

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources